The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets - PubMed (original) (raw)
Review
. 2013 Aug;1836(1):15-26.
doi: 10.1016/j.bbcan.2013.02.003. Epub 2013 Feb 19.
Affiliations
- PMID: 23428608
- DOI: 10.1016/j.bbcan.2013.02.003
Review
The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets
Jianzhou Cui et al. Biochim Biophys Acta. 2013 Aug.
Abstract
Autophagy is an evolutionarily conserved pathway for degradation of cytoplasmic proteins and organelles via lysosome. Proteins coded by the autophagy-related genes (Atgs) are the core molecular machinery in control of autophagy. Among the various biological functions of autophagy identified so far, the link between autophagy and cancer is probably among the most extensively studied and is often viewed as controversial. Autophagy might exert a dual role in cancer development: autophagy can serve as an anti-tumor mechanism, as defective autophagy (e.g., heterozygous knockdown Beclin 1 and Atg7 in mice) promotes the malignant transformation and spontaneous tumors. On the other hand, autophagy functions as a protective or survival mechanism in cancer cells against cellular stress (e.g., nutrient deprivation, hypoxia and DNA damage) and hence promotes tumorigenesis and causes resistance to therapeutic agents. Liver cancer is one of the common cancers with well-established etiological factors including hepatitis virus infection and environmental carcinogens such as aflatoxin and alcohol exposure. In recent years, the involvement of autophagy in liver cancer has been increasingly studied. Here, we aim to provide a systematic review on the close cross-talks between autophagy and liver cancer, and summarize the current status in development of novel liver cancer therapeutic approaches by targeting autophagy. It is believed that understanding the molecular mechanisms underlying the autophagy modulation and liver cancer development may provoke the translational studies that ultimately lead to new therapeutic strategies for liver cancer.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
- Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer.
Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B. Dalby KN, et al. Autophagy. 2010 Apr;6(3):322-9. doi: 10.4161/auto.6.3.11625. Epub 2010 Apr 26. Autophagy. 2010. PMID: 20224296 Free PMC article. Review. - The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets.
Cui J, Shen HM, Lim LHK. Cui J, et al. Pharmaceuticals (Basel). 2020 Nov 28;13(12):432. doi: 10.3390/ph13120432. Pharmaceuticals (Basel). 2020. PMID: 33260729 Free PMC article. Review. - Manipulation of autophagy by MIR375 generates antitumor effects in liver cancer.
Chang Y, Lin J, Tsung A. Chang Y, et al. Autophagy. 2012 Dec;8(12):1833-4. doi: 10.4161/auto.21796. Autophagy. 2012. PMID: 22929050 Free PMC article. - Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.
Chen P, Hu T, Liang Y, Jiang Y, Pan Y, Li C, Zhang P, Wei D, Li P, Jeong LS, Chu Y, Qi H, Yang M, Hoffman RM, Dong Z, Jia L. Chen P, et al. Oncotarget. 2015 Apr 20;6(11):9002-17. doi: 10.18632/oncotarget.3282. Oncotarget. 2015. PMID: 25797246 Free PMC article. - Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G, Levine B. Qu X, et al. J Clin Invest. 2003 Dec;112(12):1809-20. doi: 10.1172/JCI20039. Epub 2003 Nov 24. J Clin Invest. 2003. PMID: 14638851 Free PMC article.
Cited by
- Autophagy and liver disease.
Puri P. Puri P. J Clin Exp Hepatol. 2013 Sep;3(3):262-4. doi: 10.1016/j.jceh.2013.08.012. Epub 2013 Sep 16. J Clin Exp Hepatol. 2013. PMID: 25755510 Free PMC article. No abstract available. - Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review).
Ye G, Ye M, Jin X. Ye G, et al. Am J Cancer Res. 2024 Sep 15;14(9):4113-4171. doi: 10.62347/UJVP4361. eCollection 2024. Am J Cancer Res. 2024. PMID: 39417171 Free PMC article. Review. - TDP-43/HDAC6 axis promoted tumor progression and regulated nutrient deprivation-induced autophagy in glioblastoma.
Lin TW, Chen MT, Lin LT, Huang PI, Lo WL, Yang YP, Lu KH, Chen YW, Chiou SH, Wu CW. Lin TW, et al. Oncotarget. 2017 May 18;8(34):56612-56625. doi: 10.18632/oncotarget.17979. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915616 Free PMC article. - Arginine dependence of tumor cells: targeting a chink in cancer's armor.
Patil MD, Bhaumik J, Babykutty S, Banerjee UC, Fukumura D. Patil MD, et al. Oncogene. 2016 Sep 22;35(38):4957-72. doi: 10.1038/onc.2016.37. Epub 2016 Apr 25. Oncogene. 2016. PMID: 27109103 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical